Author

A. Pich

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Approach:experimental assay· 3 Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1

Frequent Co-Authors

A. Disanza· 1 shared A. Just· 1 shared A. Nayak· 1 shared A. Pfanne· 1 shared A. Richter· 1 shared A. Schmidt· 1 shared B. Khan· 1 shared B. Mhlekude· 1 shared

Activity by Year

2022-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Disanza

Author profile →

4 papers

Recent·Most cited

Sorafenib induces muscle wasting by disrupting the activity of distinct chromatin regulators

B. Khan, C. Lanzuolo, V. Rosti, P. A. Santarelli, A. Pich, T. Kraft, M. Amrute-Nayak, A. Nayak

This study shows Sorafenib causes muscle wasting by disrupting chromatin regulators, leading to transcriptional changes and impaired muscle function.

bioRxiv · Jan 4, 2024 · PreprintCell Biology

SGLT2 inhibitors attenuate endothelial to mesenchymal transition and cardiac fibroblast activation

K. Schmidt, A. Schmidt, S. Gross, A. Just, A. Pfanne, M. Fuchs, M. Jordan, E. Mohr, A. Pich, J. Fiedler, T. Thum

This study shows SGLT2 inhibitors reduce endothelial to mesenchymal transition and cardiac fibroblast activation through effects on mitochondrial respiration, actin cytoskeleton, and specific transporters.

bioRxiv · Dec 18, 2023Pharmacology & Toxicology

Pharmacological inhibition of bromodomain and extra-terminal proteins induces NRF-2-mediated inhibition of SARS-CoV-2 replication and is subject to viral antagonism

B. Mhlekude, D. Postmus, J. Weiner, S. Stenzel, F. J. Zapatero-Belinchon, R. Olmer, J. Jansen, A. Richter, J. Heinze, N. Heinemann, B. Muhlemann, S. Schroeder, T. C. Jones, M. A. Muller, C. Drosten, , C. Goffinet

This study shows JQ-1 inhibits SARS-CoV-2 replication via NRF-2 activation but is counteracted by viral antagonism, leading to transient antiviral effects.

bioRxiv · Sep 22, 2022 · PreprintMicrobiology

Ena/VASP clustering at microspike tips involves Lamellipodin but not I-BAR proteins, and absolutely requires unconventional Myosin-X

T. Pokrant, J. I. Hein, S. Koerber, A. Disanza, A. Pich, G. Scita, K. Rottner, J. Faix

This study identifies unconventional Myosin-X as essential for Ena/VASP clustering and microspike formation, while showing Lamellipodin is involved but inverse BAR-domain proteins are not.

bioRxiv · May 12, 2022Cell Biology